However, it should be pointed out that drugs targeting AKT signaling directly or indirectly can promote the formation of AKT1low QCCs, but cannot eliminate them [62,63], and the issue of how to maintain QCCs for a long time without drug resistance and tumor relapse is still a challenge. Here, AKT1 is linked to neoplasm.